DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alimera Sciences, Inc. (ALIM)
« Back to company indexALIM Chatter Timeline
Stock Ticker for ALIM
Most Active Tweeters for ALIM
| User | Tweets |
|---|---|
| @d_kab1 | 2 |
| @TickerReport | 2 |
| @TheMarketsDaily | 2 |
| @macondailynews | 2 |
| @bbnsnews | 2 |
Recent Tweets for ALIM
 |
@mrland_news Block Trade: ALIM 1.0M @ $0.42 at the bid $ALIM https://t.co/eWywaIjpA0 @benzinga 10:09am |
 |
@TickerReport Alimera Sciences Inc $ALIM Short Interest Update https://t.co/9OeVcpi9DW September 15th 2019, 4:09am |
 |
@stocknewstimes Alimera Sciences $ALIM Stock Price Up 6% https://t.co/DfjfXX8DB3 September 14th 2019, 1:09am |
 |
@TheMarketsDaily Alimera Sciences $ALIM Stock Price Up 6% https://t.co/m9wP1wQYxq September 14th 2019, 1:09am |
 |
@macondailynews Alimera Sciences $ALIM Stock Price Up 6% https://t.co/m5qbWal8wR September 14th 2019, 1:09am |
 |
@Stock_News_Now $ALIM: New SEC Filing for ALIM: Form 8-K (No. 0001267602-19-000111): https://t.co/xSvX11i9Lb September 13th 2019, 4:09pm |
 |
@confcalltran Notice of Delisting or Failure to Satisfy a Continued Listing Rule or https://t.co/msFtiHRDRn $ALIM September 13th 2019, 4:09pm |
 |
@AmericanBanking Alimera Sciences Inc $ALIM Short Interest Update https://t.co/xLaBliIsUg #stocks September 13th 2019, 1:09am |
 |
@bbnsnews Alimera Sciences $ALIM Upgraded to Hold by Zacks Investment Research https://t.co/500nXkNZ8R September 12th 2019, 9:09pm |
 |
@d_kab1 most of stuff from yesterday flat or down only $pins $alim doing well September 12th 2019, 11:09am |
 |
@StockNewsNow $ALIM Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN®… https://t.co/EZKRAcLQpD September 12th 2019, 11:09am |
 |
@MarketCurrents $ALIM - Alimera expands Iluvien distribution deal with Horus; shares ahead 10% https://t.co/DyPANpxtCp September 12th 2019, 10:09am |
 |
@Optionsavvy $ALIM sub 1 that hit my radar on scans but wanted to look at it first. acting well https://t.co/ozJN7KfzS7 September 12th 2019, 9:09am |
 |
@ez_alertz $ALIM Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN… https://t.co/cC2EUOBB3U September 12th 2019, 8:09am |
 |
@VisualStockRSRC $ALIM - Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing https://t.co/1sG1w0oLOB September 12th 2019, 8:09am |
 |
@ConsumerFeed Alimera Sciences $ALIM Stock Price Up 6% https://t.co/cJkH50u09u September 12th 2019, 1:09am |
 |
@IRAMarketReport Alimera Sciences $ALIM Trading Up 6% https://t.co/4HL3uORb0U #markets September 12th 2019, 1:09am |
 |
@chaffeybreeze Alimera Sciences $ALIM Trading Up 6% https://t.co/t1tWG3AHkr #stocks September 12th 2019, 1:09am |
|
@d_kab1 $ALIM high volume today 998K vs 10d avg 178K, hammer candle in falling wedge on daily (1st pic) and breaking RSI re… https://t.co/8gQoVFYG2C September 11th 2019, 6:09pm |
|
@ConsumerFeed Alimera Sciences $ALIM Upgraded to “Hold” at Zacks Investment Research https://t.co/251qST0zrr September 11th 2019, 5:09pm |
 |
@dakotafinancial Alimera Sciences Inc $ALIM Given Average Rating of “Buy” by Brokerages https://t.co/OT0c610p7L September 9th 2019, 9:09pm |
|
@macondailynews Alimera Sciences $ALIM Lifted to Hold at Zacks Investment Research https://t.co/PgopyHyqsb September 9th 2019, 4:09am |
|
@TheMarketsDaily Alimera Sciences $ALIM Lifted to Hold at Zacks Investment Research https://t.co/zQvRhpU7XE September 9th 2019, 4:09am |
|
@TickerReport Alimera Sciences $ALIM Lifted to Hold at Zacks Investment Research https://t.co/eHA49HPf5B September 8th 2019, 9:09am |
 |
@registrarjourn Alimera Sciences $ALIM Lifted to Hold at Zacks Investment Research https://t.co/nSiGrBz5v2 September 8th 2019, 9:09am |
 |
@EnterpriseLeade Alimera Sciences $ALIM Lifted to Hold at Zacks Investment Research https://t.co/u7XlKDltlF September 8th 2019, 9:09am |
|
@bbnsnews Alimera Sciences Inc $ALIM Receives $3.00 Consensus PT from Brokerages https://t.co/jGCGWrvwKw September 7th 2019, 8:09pm |
 |
@OlympiaReport $13.00 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/bCmYXkpgzZ August 10th 2019, 8:08pm |
 |
@WeekHerald Alimera Sciences Inc $ALIM Expected to Post Quarterly Sales of $13.00 Million https://t.co/6CgcwMGC8K August 10th 2019, 7:08pm |
 |
@ThisLincolnian $13.00 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/7vUc6QJPCb August 10th 2019, 7:08pm |
|
@AmericanBanking Alimera Sciences Inc $ALIM Given Consensus Rating of “Buy” by Analysts https://t.co/jDOVQ5KZJZ #stocks August 10th 2019, 12:08pm |
|
@AmericanBanking Alimera Sciences Inc $ALIM Given Consensus Rating of “Buy” by Analysts https://t.co/x7NvUsmpWE #stocks August 10th 2019, 10:08am |
 |
@dispatchtribune Alimera Sciences $ALIM Downgraded by Zacks Investment Research https://t.co/rSrfERKsV7 August 9th 2019, 5:08am |
|
@EnterpriseLeade Alimera Sciences $ALIM Downgraded by Zacks Investment Research https://t.co/m7urXUamP0 August 9th 2019, 5:08am |
|
@registrarjourn Alimera Sciences $ALIM Downgraded by Zacks Investment Research https://t.co/VuUOr365Sd August 9th 2019, 5:08am |
|
@macondailynews Brokerages Expect Alimera Sciences Inc $ALIM Will Post Quarterly Sales of $13.00 Million https://t.co/Ufz3cXYKvV August 8th 2019, 11:08am |
|
@Stock_News_Now $ALIM: New SEC Filing for ALIM: Form 10-Q (No. 0001267602-19-000106): https://t.co/chU9t92UTt August 6th 2019, 4:08pm |
 |
@StockTexts $ALIM Alimera Sciences, Inc. SEC Filing: Form 10-Q https://t.co/bzfC9fVxI8 August 6th 2019, 4:08pm |
 |
@filingsdb New Form 10-Q filed by ALIMERA SCIENCES INC $ALIM - https://t.co/TeD9CvnaxZ August 6th 2019, 4:08pm |
|
@TickerReport Alimera Sciences $ALIM Lowered to “Sell” at Zacks Investment Research https://t.co/2HDdeAyYND August 6th 2019, 2:08pm |
|
@macondailynews Alimera Sciences $ALIM Lowered to “Sell” at Zacks Investment Research https://t.co/XlfbqDa6dj August 6th 2019, 2:08pm |
 |
@MaisaCorp $ALIM Announces Iluvien Regulatory Approval In Australia For The Treatment Of Diabetic Macular Edema August 5th 2019, 5:08pm |
 |
@TranscriptDaily Alimera Sciences $ALIM Downgraded to Sell at Zacks Investment Research https://t.co/rl3Rpgy8ms August 5th 2019, 4:08pm |
|
@TheMarketsDaily Alimera Sciences $ALIM Downgraded to Sell at Zacks Investment Research https://t.co/MrGA4LxU99 August 5th 2019, 4:08pm |
|
@stocknewstimes Alimera Sciences $ALIM Downgraded to Sell at Zacks Investment Research https://t.co/SCXmO6yucP August 5th 2019, 4:08pm |
 |
@StockNewsWires $ALIM: Alimera’s ILUVIEN now approved in Australia for DME: https://t.co/Rj8vLXN59f August 5th 2019, 10:08am |
 |
@Gambiste1 RT @MarketCurrents: $ALIM - Alimera's ILUVIEN now approved in Australia for DME https://t.co/HrQGzauOQt August 5th 2019, 10:08am |
|
@MarketCurrents $ALIM - Alimera's ILUVIEN now approved in Australia for DME https://t.co/HrQGzauOQt August 5th 2019, 9:08am |
|
@AmericanBanking Zacks: Brokerages Anticipate Alimera Sciences Inc $ALIM Will Post Quarterly Sales of $13.60 Million https://t.co/Y2OZoVsSWJ #stocks August 5th 2019, 1:08am |
|
@dakotafinancial Alimera Sciences $ALIM Raised to Buy at ValuEngine https://t.co/Ic8eyNSqgc August 4th 2019, 11:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.